EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy?

Ramesh Mazhari, Judith Hsia

Vascular Health and Risk Management · 2005

DOI: 10.2147/vhrm.1.2.111.64084 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vascular Health and Risk Management, 2005. Verfasst von Ramesh Mazhari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, George Washington University, Washington, DC 20037, USA. Hauptthemen laut MEDLINE: Estrogen Replacement Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peripheral arterial disease (PAD), like coronary heart disease, is a clinical manifestation of atherosclerosis and is associated with increased mortality. Although atherosclerotic cardiovascular disease is the leading cause of death for women as well as for men, PAD in women has received less attention than coronary heart disease or stroke. This paper reviews the prevalence of PAD, its risk factors, clinical significance, and management in women. One gender-specific therapeutic issue of particular interest to practitioners and the lay public is the role of postmenopausal hormone therapy. Prior to completion of the Heart and Estrogen/Progestin Replacement Study and the Women's Health Initiative Hormone Trials, postmenopausal hormone therapy was believed to exert antiatherosclerotic effects and to thereby reduce coronary heart disease risk in women on the basis of case-control and cohort studies. This review particularly focuses on the role, if any, of postmenopausal hormone therapy for prevention or treatment of PAD, which was a pre-specified secondary outcome for these three randomized trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Estrogen Replacement TherapyAngiotensin-Converting Enzyme InhibitorsAtherosclerosisFemaleHumansHypolipidemic AgentsPeripheral Vascular DiseasesPlatelet Aggregation InhibitorsPrevalenceRisk FactorsSex DistributionSex FactorsTreatment Outcome

Substanzen

Angiotensin-Converting Enzyme InhibitorsHypolipidemic AgentsPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Division of Cardiology, George Washington University, Washington, DC 20037, USA.

Zitieren

APA

Mazhari, R., & Hsia, J. (2005). Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy?. Vascular Health and Risk Management. https://doi.org/10.2147/vhrm.1.2.111.64084

Vancouver

Mazhari R, Hsia J. Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy?. Vascular Health and Risk Management. 2005. doi:10.2147/vhrm.1.2.111.64084

BibTeX
@article{Mazhari2005,
  author = {Mazhari, Ramesh and Hsia, Judith},
  title = {Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy?},
  journal = {Vascular Health and Risk Management},
  year = {2005},
  doi = {10.2147/vhrm.1.2.111.64084}
}
Kostenlos starten →